Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP227353.RArK1tkclhKICKoLCfljRzCR7Su_bMVVA-rJCCbDSyh6I130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227353.RArK1tkclhKICKoLCfljRzCR7Su_bMVVA-rJCCbDSyh6I130_provenance.
• NP296242.RABQ0TZxk9h_q-LjD_avnZolX5oaJJx3LznR2hoP5Ni30130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296242.RABQ0TZxk9h_q-LjD_avnZolX5oaJJx3LznR2hoP5Ni30130_provenance.
• NP882538.RAhYlKZD0Uja7myH3J-SdiMHa4lzChY7Dq0cWq4fxH1k0130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882538.RAhYlKZD0Uja7myH3J-SdiMHa4lzChY7Dq0cWq4fxH1k0130_provenance.
• NP434777.RAbJ9rCbQJK6Ph9NR_--oD2Fi4_SpngKW6VEmA9cP43uA130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434777.RAbJ9rCbQJK6Ph9NR_--oD2Fi4_SpngKW6VEmA9cP43uA130_provenance.
• NP233306.RAM_ksBWo6FEZHfA_RRT8i55oue0YOMjaToPUpwn-JZIQ130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233306.RAM_ksBWo6FEZHfA_RRT8i55oue0YOMjaToPUpwn-JZIQ130_provenance.
• NP745256.RAwX89Ky70Z-DrQBgtJJIHu1938Kxx0o2PuNxxS_dfP60130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745256.RAwX89Ky70Z-DrQBgtJJIHu1938Kxx0o2PuNxxS_dfP60130_provenance.
• NP682419.RAUk7Q0uPjzxzEVpGA8ym5fP4yhF8X3bPz8P_OyQDI8UU130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682419.RAUk7Q0uPjzxzEVpGA8ym5fP4yhF8X3bPz8P_OyQDI8UU130_provenance.
• assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP581228.RAZsO2rnKoJ-JbG9M2oW68-3Sbv1OveCobQxf9kxX27Po130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581228.RAZsO2rnKoJ-JbG9M2oW68-3Sbv1OveCobQxf9kxX27Po130_provenance.
• assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP682578.RArFEIROdPZXXwXPhfXKMR1h2Z9LBUFXJb4NvmKSyML0U130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682578.RArFEIROdPZXXwXPhfXKMR1h2Z9LBUFXJb4NvmKSyML0U130_provenance.
• NP964042.RAulLpXAZPjh58YBYtDPRHAPZeSrS6dZzMkVT-LmpzktQ130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964042.RAulLpXAZPjh58YBYtDPRHAPZeSrS6dZzMkVT-LmpzktQ130_provenance.
• NP581227.RAhSqhkUz2yy-GqXRiTqh-QVcsHK-UXFt-CtVaLOVhz1o130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581227.RAhSqhkUz2yy-GqXRiTqh-QVcsHK-UXFt-CtVaLOVhz1o130_provenance.
• NP964005.RAInXU1HMXkOyEC-Z5V7xuZdpBpu4YlGPRv4zodD8HKyw130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964005.RAInXU1HMXkOyEC-Z5V7xuZdpBpu4YlGPRv4zodD8HKyw130_provenance.
• NP964027.RAG4iUTikAfhO17yUChc8fAE64zCziDmMABX5wJNOhHUQ130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964027.RAG4iUTikAfhO17yUChc8fAE64zCziDmMABX5wJNOhHUQ130_provenance.
• NP682559.RAJ8i3gB5P0WhQXyI1lfRmDLI_ADg-CHX5F4fyrNTuUeE130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682559.RAJ8i3gB5P0WhQXyI1lfRmDLI_ADg-CHX5F4fyrNTuUeE130_provenance.
• NP581223.RANhUamerR91X68lsvLdR2MnUsfrPkz1V78m-1Pc0JCqM130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581223.RANhUamerR91X68lsvLdR2MnUsfrPkz1V78m-1Pc0JCqM130_provenance.
• NP581226.RAxElNpI_O6bQjk-hYTjqnAz2R9b-ttLNj-AOu2PPLfQM130_assertion description "[Furthermore, intense NAC-1 immunoreactivity in primary tumors predicts early recurrence in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581226.RAxElNpI_O6bQjk-hYTjqnAz2R9b-ttLNj-AOu2PPLfQM130_provenance.